Company Profile

Taconic Biosciences Inc (AKA: Taconic Farms Inc)
Profile last edited on: 10/4/2023      CAGE: 0S6Z4      UEI: DLTYNNJFGPM5

Business Identifier: Transgenic lab animals: developing and delivering animal models and related laboratory services for biomedical research
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

One Hudson City Centre
Hudson, NY 12534
   (518) 697-3900
Location: Single
Congr. District: 19
County: Columbia

Public Profile

Still operation though - due to having grown the exceed SBIR size standards - not program involved since 1998, Taconic provides high quality, precisely defined laboratory rats, mice and services for biomedical research. Taconic has a Quality Assurance Program that encompasses health monitoring, genetic integrity, environmental control and nutrition. In November, 2007, Taconic Farms, Inc. took a major stake in Artemis Pharmaceuticals GmbH from Artemis' parent company Exelixis, Inc., of South San Francisco (Nasdaq:EXEL). Artemis Pharmaceuticals GmbH changed its name to TaconicArtemis GmbH. In 2019, the firm had been acquired by HIG Capital. In November 2022 it was reported that Avista Capital Partners had acquired Taconic Biosciences for an undisclosed amount

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1998 1 NIH $100,000
Project Title: Mouse Models For Studies Of Aging And Neuronal Diseases
1995 1 NIH $99,999
Project Title: Tim Rag-2 Mice as Xenograft Hosts in Cancer Chemotherapy

Key People / Management

  Joseph Phelan -- President

  James G Geistfeld

Company News

There are no news available.